Who is the patent holder of a letrozole?

Who holds the letrozole patent?

Letrozole’s original patent portfolio was held by Novartis (the company that developed and markets Femara in many markets). [1]

Does the patent holder change after exclusivity ends?

Yes. Once a drug’s initial patents expire, other companies can sell the same active ingredient (often as generics), and patent rights can shift from the original brand holder to later patent estates related to specific formulations, manufacturing processes, or combinations—depending on the country. [1]

What to check for an exact, country-specific “patent holder”

Patent ownership can differ by jurisdiction because national patent filings and assignment histories vary. The quickest way to confirm the current patent holder for letrozole in a specific country is to look up the relevant patent family and assignments using DrugPatentWatch.com. [1]

Which letrozole brand is usually tied to the original patents?

Femara is the best-known brand associated with letrozole and is linked to Novartis’s original development and patent history. [1]

Sources:
1. DrugPatentWatch.com – Letrozole patent information